AZ-话题@MedSci

#AZ#

260篇内容 | 4185人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1714787, encodeId=4bc31e147874c, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Food Chem：甜味蛋白质brazzein的抗氧化、抗炎和抗过敏活性, objectType=article, longId=141616, objectId=6bf114161623, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bf114161623, replyNumber=0, likeNumber=77, createdTime=2018-07-22, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bf114161623, moduleTitle=Food Chem：甜味蛋白质brazzein的抗氧化、抗炎和抗过敏活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bf114161623)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714776, encodeId=b6621e147760c, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Lancet oncol：Tazemetostat，EZH2抑制剂，用于B细胞非霍奇金淋巴瘤和晚期固体肿瘤治疗效率良好，且安全性良好, objectType=article, longId=134756, objectId=8eb0134e56d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8eb0134e56d7, replyNumber=0, likeNumber=78, createdTime=2019-03-18, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8eb0134e56d7, moduleTitle=Lancet oncol：Tazemetostat，EZH2抑制剂，用于B细胞非霍奇金淋巴瘤和晚期固体肿瘤治疗效率良好，且安全性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8eb0134e56d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714800, encodeId=19c21e14800b6, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Immun Inflamm Dis：永久过敏性鼻炎患者中，MP-AzeFlu治疗效果分析, objectType=article, longId=151881, objectId=b3a0151881b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3a0151881b2, replyNumber=0, likeNumber=54, createdTime=2019-06-13, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3a0151881b2, moduleTitle=Immun Inflamm Dis：永久过敏性鼻炎患者中，MP-AzeFlu治疗效果分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3a0151881b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714761, encodeId=013e1e14761ff, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=J Clin Invest：PTEN/AKT和Hippo/YAP/TAZ通路之间的交叉串扰加速了NAFLD和肝癌的发生, objectType=article, longId=129225, objectId=2169129225fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2169129225fd, replyNumber=0, likeNumber=55, createdTime=2018-09-30, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2169129225fd, moduleTitle=J Clin Invest：PTEN/AKT和Hippo/YAP/TAZ通路之间的交叉串扰加速了NAFLD和肝癌的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2169129225fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714785, encodeId=4a8f1e1478572, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Liver Int：PPARalpha/gamma激活剂—saroglitazar可改善NASH小鼠的肝脏功能和组织病理水平, objectType=article, longId=140209, objectId=9bfd1402098d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9bfd1402098d, replyNumber=0, likeNumber=90, createdTime=2019-05-01, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9bfd1402098d, moduleTitle=Liver Int：PPARalpha/gamma激活剂—saroglitazar可改善NASH小鼠的肝脏功能和组织病理水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9bfd1402098d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714773, encodeId=15f41e14773b7, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Braz J Med Biol Res：2-甲基2-丁醇通过细胞周期停滞和自噬抑制人成视网膜细胞瘤, objectType=article, longId=133226, objectId=e3ae1332265e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3ae1332265e, replyNumber=0, likeNumber=75, createdTime=2019-02-22, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3ae1332265e, moduleTitle=Braz J Med Biol Res：2-甲基2-丁醇通过细胞周期停滞和自噬抑制人成视网膜细胞瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3ae1332265e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714760, encodeId=01ab1e1476060, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Braz Dent J：种植牙能使用几年？, objectType=article, longId=128775, objectId=77ac128e7573, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77ac128e7573, replyNumber=0, likeNumber=53, createdTime=2018-11-17, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77ac128e7573, moduleTitle=Braz Dent J：种植牙能使用几年？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77ac128e7573)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714799, encodeId=6d061e1479923, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Braz Oral Res：全身应用褪黑激素可增加下颌骨牵引成骨中的骨形成, objectType=article, longId=150528, objectId=b12715052808, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b12715052808, replyNumber=0, likeNumber=25, createdTime=2018-12-14, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b12715052808, moduleTitle=Braz Oral Res：全身应用褪黑激素可增加下颌骨牵引成骨中的骨形成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b12715052808)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714770, encodeId=aceb1e1477024, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Stem Cell Res Ther：TAZ的药理学活化增强了脂肪源性干细胞的成骨分化和骨形成, objectType=article, longId=132396, objectId=b7ab132396a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7ab132396a1, replyNumber=0, likeNumber=58, createdTime=2018-06-29, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7ab132396a1, moduleTitle=Stem Cell Res Ther：TAZ的药理学活化增强了脂肪源性干细胞的成骨分化和骨形成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7ab132396a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714780, encodeId=c67a1e1478038, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=唑来膦酸辅助减少乳腺癌患者的骨折：AZURE（BIG 01/04）研究, objectType=article, longId=136868, objectId=d647136868ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d647136868ef, replyNumber=0, likeNumber=82, createdTime=2019-03-27, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d647136868ef, moduleTitle=唑来膦酸辅助减少乳腺癌患者的骨折：AZURE（BIG 01/04）研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d647136868ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714793, encodeId=eedd1e1479344, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=阿斯利康（AstraZeneca）1.1亿美元了结美国Seroquel / Crestor药物诉讼案, objectType=article, longId=146241, objectId=accc14624103, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=accc14624103, replyNumber=0, likeNumber=48, createdTime=2018-10-05, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=accc14624103, moduleTitle=阿斯利康（AstraZeneca）1.1亿美元了结美国Seroquel / Crestor药物诉讼案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=accc14624103)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714771, encodeId=f5b51e1477109, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=J Cell Biol：Kindlin-2通过控制YAP1/TAZ调节间充质干细胞分化, objectType=article, longId=132538, objectId=e995132538b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e995132538b3, replyNumber=0, likeNumber=56, createdTime=2018-04-09, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e995132538b3, moduleTitle=J Cell Biol：Kindlin-2通过控制YAP1/TAZ调节间充质干细胞分化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e995132538b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714786, encodeId=c97d1e14786c4, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Braz Oral Res：浓缩生长因子可有效促进牙槽裂缺损的成骨, objectType=article, longId=141581, objectId=971a14158145, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=971a14158145, replyNumber=0, likeNumber=67, createdTime=2019-03-20, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=971a14158145, moduleTitle=Braz Oral Res：浓缩生长因子可有效促进牙槽裂缺损的成骨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=971a14158145)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714794, encodeId=b58f1e1479471, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=CLIN CANCER RES：AZD9496治疗ER+/HER2-晚期乳腺癌, objectType=article, longId=146595, objectId=ecee146595dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ecee146595dd, replyNumber=0, likeNumber=58, createdTime=2018-12-04, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ecee146595dd, moduleTitle=CLIN CANCER RES：AZD9496治疗ER+/HER2-晚期乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ecee146595dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714783, encodeId=05861e1478304, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=CLIN CANCER RES：AZD5363治疗实体肿瘤，PIK3CA突变乳腺癌和妇科恶性肿瘤, objectType=article, longId=137692, objectId=2bc713e69248, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bc713e69248, replyNumber=0, likeNumber=92, createdTime=2018-06-07, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bc713e69248, moduleTitle=CLIN CANCER RES：AZD5363治疗实体肿瘤，PIK3CA突变乳腺癌和妇科恶性肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2bc713e69248)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714782, encodeId=ad561e14782e8, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=J Hazard Mater：GO对抗菌药物转运的影响, objectType=article, longId=137322, objectId=a49213e3224e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a49213e3224e, replyNumber=0, likeNumber=50, createdTime=2018-07-22, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a49213e3224e, moduleTitle=J Hazard Mater：GO对抗菌药物转运的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a49213e3224e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714774, encodeId=b8331e1477440, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=欧盟批准AZ的Lokelma治疗高钾血症, objectType=article, longId=133427, objectId=e28b13342e74, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e28b13342e74, replyNumber=0, likeNumber=69, createdTime=2018-12-03, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e28b13342e74, moduleTitle=欧盟批准AZ的Lokelma治疗高钾血症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e28b13342e74)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714788, encodeId=f8cf1e1478822, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=CLIN CANCER RES：AZD1775联合新辅助多西他赛和顺铂治疗头颈部鳞状细胞癌, objectType=article, longId=141953, objectId=6d9f14195367, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d9f14195367, replyNumber=0, likeNumber=59, createdTime=2019-01-13, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d9f14195367, moduleTitle=CLIN CANCER RES：AZD1775联合新辅助多西他赛和顺铂治疗头颈部鳞状细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d9f14195367)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714754, encodeId=52551e1475451, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=Gut：Vonoprazan可以预防低剂量阿司匹林相关的溃疡复发！, objectType=article, longId=122090, objectId=eb96122090d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb96122090d9, replyNumber=0, likeNumber=74, createdTime=2018-05-04, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb96122090d9, moduleTitle=Gut：Vonoprazan可以预防低剂量阿司匹林相关的溃疡复发！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb96122090d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1714756, encodeId=5df41e147564f, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, objectTitle=CLIN CANCER RES：AZD8186抑制PI3Kβ调节PTEN缺失肿瘤关键代谢通路, objectType=article, longId=124474, objectId=6cb61244e4be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cb61244e4be, replyNumber=0, likeNumber=58, createdTime=2018-11-21, rootId=0, userName=12498e5fm22(暂无昵称), userId=9e5031899089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cb61244e4be, moduleTitle=CLIN CANCER RES：AZD8186抑制PI3Kβ调节PTEN缺失肿瘤关键代谢通路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cb61244e4be)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

AZ

2020-05-29

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Food Chem：甜味蛋白质brazzein的抗氧化、抗炎和抗过敏活性

2018-07-22

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Lancet oncol：Tazemetostat，EZH2抑制剂，用于B细胞非霍奇金淋巴瘤和晚期固体肿瘤治疗效率良好，且安全性良好

2019-03-18

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Immun Inflamm Dis：永久过敏性鼻炎患者中，MP-AzeFlu治疗效果分析

2019-06-13

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

J Clin Invest：PTEN/AKT和Hippo/YAP/TAZ通路之间的交叉串扰加速了NAFLD和肝癌的发生

2018-09-30

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Liver Int：PPARalpha/gamma激活剂—saroglitazar可改善NASH小鼠的肝脏功能和组织病理水平

2019-05-01

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Braz J Med Biol Res：2-甲基2-丁醇通过细胞周期停滞和自噬抑制人成视网膜细胞瘤

2019-02-22

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Braz Dent J：种植牙能使用几年？

2018-11-17

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Braz Oral Res：全身应用褪黑激素可增加下颌骨牵引成骨中的骨形成

2018-12-14

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Stem Cell Res Ther：TAZ的药理学活化增强了脂肪源性干细胞的成骨分化和骨形成

2018-06-29

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

唑来膦酸辅助减少乳腺癌患者的骨折：AZURE（BIG 01/04）研究

2019-03-27

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

阿斯利康（AstraZeneca）1.1亿美元了结美国Seroquel / Crestor药物诉讼案

2018-10-05

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

J Cell Biol：Kindlin-2通过控制YAP1/TAZ调节间充质干细胞分化

2018-04-09

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Braz Oral Res：浓缩生长因子可有效促进牙槽裂缺损的成骨

2019-03-20

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

CLIN CANCER RES：AZD9496治疗ER+/HER2-晚期乳腺癌

2018-12-04

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

CLIN CANCER RES：AZD5363治疗实体肿瘤，PIK3CA突变乳腺癌和妇科恶性肿瘤

2018-06-07

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

J Hazard Mater：GO对抗菌药物转运的影响

2018-07-22

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

欧盟批准AZ的Lokelma治疗高钾血症

2018-12-03

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

CLIN CANCER RES：AZD1775联合新辅助多西他赛和顺铂治疗头颈部鳞状细胞癌

2019-01-13

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

Gut：Vonoprazan可以预防低剂量阿司匹林相关的溃疡复发！

2018-05-04

12498e5fm22(暂无昵称) (审核中...)

前往app查看评论内容

#AZ#

CLIN CANCER RES：AZD8186抑制PI3Kβ调节PTEN缺失肿瘤关键代谢通路

2018-11-21

科室
- - 订阅+
  - 更多科室
工具
服务